Investment
Phased capital partnership
Veevia is raising capital in structured tranches aligned to product milestones — not a single lump-sum ask. We are building a hands-free, AI-powered clinical workflow platform starting in dentistry, with a token- and subscription-based commercial model, HIPAA-aligned architecture, and strategic partner Nisum for AI development.
Dentistry → procedure-based care
Market entry
250 clinician cohort
Early access
CES 2026 concept launch
Showcase
Nisum
Partners
ADA / ANSI / ISO alignment
Standards
Token + subscription
Model
Investment thesis
Why Veevia, why now
- Procedure-room workflow is still fragmented — clinicians touch too many devices during care.
- Voice-first, hands-free documentation reduces interruptions, touchpoints, and after-hours charting.
- Phase 1 targets dentistry with 250 early-access clinicians; the platform is designed to scale across procedure-based specialties.
- Founding team combines clinical KOL credibility, scientific validation, and operational execution across the US, LATAM, EU, and Asia.
Funding tranches
Invest by milestone — choose the tranche that matches your ticket size and risk profile.
Tranche 1
Pre-seed / Angel
$250K – $750K
Capital to develop the minimum viable product (MVP) and ship a trial version for clinical early adopters — validating hands-free workflow, documentation, and onboarding before scale.
Use of funds
- · MVP development and trial release
- · HIPAA-aligned security and compliance groundwork
- · Early clinician onboarding (first 250 seats)
- · Core engineering and partner integration (Nisum)
Milestones
- · MVP and trial version in market
- · 250 clinician early-access program live
- · Voice workflow validated in live dental procedures
- · Investor-ready metrics and clinical feedback loop
Tranche 2
Seed round
$5M
Scale medical and dental rollout across the US while expanding the marketplace to support many devices and clinical platforms — broadening reach beyond a single hardware or EHR stack.
Use of funds
- · Medical and dental market rollout
- · Marketplace expansion across devices and supporting platforms
- · Enterprise hospital and group workflow packages
- · Regulatory and standards alignment (ADA/ANSI/ISO track)
- · Token and subscription platform commercialization
Milestones
- · Multi-site dental and medical deployments
- · Marketplace live across multiple device and platform partners
- · Documented reduction in documentation time (target up to 40%)
- · Recurring revenue from subscription and token model
Tranche 3
Series A (planned)
Future institutional round
Growth capital for multi-specialty expansion, international markets, and regulated clinical features — opened after Seed milestones are met.
Use of funds
- · Specialty workflow packs beyond dentistry
- · Hong Kong, Ireland, and LATAM market entry
- · Advanced AI-AR clinical workflow at scale
- · Strategic M&A and partnership acceleration
Milestones
- · Proven unit economics across segments
- · International revenue contribution
- · Platform readiness for regulated clinical modules
Clinicians
Phase One reserve program
Clinical early access runs in parallel with our raise — 250 seats validate product-market fit before scale.
View reserve program →Due diligence
Request the investor deck
Qualified angels, family offices, and strategic investors can request our deck, financial model, and data room access.
Funding ranges are indicative and subject to diligence, term sheet, and board approval. This page does not constitute an offer to sell securities. Qualified investors should contact us for the full data room and deck.